comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 07:51:17 - browse：11542

A glass office building of MassMutual with its sign on the top left — insurance coverage from STAT — Adobe

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.

MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer. The Springfield, Mass.-based insurer hopes that when people learn they carry a genetic predisposition, they’ll take action to lower their risk through diet, exercise, and getting regular screenings.

Viewed one way, it’s a win-win: The longer its members live, the longer MassMutual can collect and invest their premiums without paying out.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Abridge raises $150m as clinical notes automation market heats up

WSS

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Chronically ill young patients struggle to find fertility info

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Flagship Pioneering startup Sonata Therapeutics lays off 21

Abridge raises $150m as clinical notes automation market heats up

JPM: CVS says Medicare Advantage patients are impacting profits

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

hotspot

Medical records are filled with copy

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Hollywood unions extend contract negotiations for actors

Surprise medical billing ban raises prices elsewhere

Novavax promises a turnaround & Lilly roils the obesity market

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

How to save PrEP access — and even expand it

Morgan Health, with ambitious aims, wants you to know it’s still here

Bright Health sells Medicare Advantage business to Molina

Secretariat’s lessons for human medicine

focus

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

GSK Flovent asthma inhalers replaced by authorized generics

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Feng Zhang CRISPR delivery startup lays off quarter of staff

Abridge raises $150m as clinical notes automation market heats up

Federal weight loss drug coverage is 30 years out of date

explore

leisure time

hotspot

Wikipedia